SB 819 (see companion bill HB 920) – Maryland

Status: Inactive / Dead
Year Introduced: 2019
Link: http://mgaleg.maryland.gov/webmga/frmMain.aspx?id=sb0819&stab=01&pid=billpage&tab=subject3&ys=2019RS

Requiring the Secretary of Health, by a certain date each year, to identify a certain number of certain prescription drugs on which the State spends a certain amount of money; requiring the Secretary to require a certain pharmaceutical manufacturer to report certain cost changes and expenditures during a certain period of time; requiring the Secretary, by a certain date each year, to publish a report on the Maryland Department of Health’s website based on the information the Secretary receives under certain provisions of the Act; etc.

Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found